Barbara A Payne insider trades: Utah Medical Products (UTMD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Barbara reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 11, 2022 | UTMD | ↓ Sell | 2,000 | $85.20 | $170K | Direct | May 11, 2022 (0d) |
| Nov 18, 2021 | UTMD | ↓ Sell | 2,000 | $111.06 | $222K | Direct | Nov 18, 2021 (0d) |
| Aug 30, 2021 | UTMD | ↓ Sell | 1,999 | $88.24 | $176K | Direct | Aug 30, 2021 (0d) |
| Aug 25, 2021 | UTMD | ↓ Sell | 1 | $88.00 | $88 | Direct | Aug 27, 2021 (2d) |
| Mar 10, 2021 | UTMD | ↓ Sell | 1,000 | $90.00 | $90K | Direct | Mar 10, 2021 (0d) |
| Jun 5, 2020 | UTMD | ↓ Sell | 1,000 | $108.00 | $108K | Direct | Jun 5, 2020 (0d) |
| Jun 2, 2020 | UTMD | ↓ Sell | 1,000 | $102.04 | $102K | Direct | Jun 4, 2020 (2d) |
| May 27, 2020 | UTMD | ↓ Sell | 1,000 | $95.00 | $95K | Direct | May 28, 2020 (1d) |
| May 26, 2020 | UTMD | ↓ Sell | 770 | $92.00 | $71K | Direct | May 27, 2020 (1d) |
| May 21, 2020 | UTMD | ↓ Sell | 230 | $92.37 | $21K | Direct | May 22, 2020 (1d) |
| May 18, 2020 | UTMD | ↓ Sell | 1,000 | $87.00 | $87K | Direct | May 19, 2020 (1d) |
| Nov 19, 2019 | UTMD | ↓ Sell | 694 | $102.25 | $71K | Direct | Nov 19, 2019 (0d) |
| Nov 11, 2019 | UTMD | ↓ Sell | 6 | $104.00 | $624 | Direct | Nov 13, 2019 (2d) |
| Feb 27, 2019 | UTMD | ↓ Sell | 1,525 | $85.76 | $131K | Direct | Feb 28, 2019 (1d) |
| Feb 20, 2019 | UTMD | ↓ Sell | 1 | $92.00 | $92 | Direct | Feb 22, 2019 (2d) |
| Feb 15, 2019 | UTMD | ↓ Sell | 2,468 | $92.28 | $228K | Direct | Feb 15, 2019 (0d) |
| Nov 28, 2018 | UTMD | ↓ Sell | 1,100 | $93.79 | $103K | Direct | Nov 28, 2018 (0d) |
| Jul 27, 2018 | UTMD | ↓ Sell | 1,500 | $96.00 | $144K | Direct | Jul 30, 2018 (3d) |
| May 7, 2018 | UTMD | ↓ Sell | 2,406 | $104.56 | $252K | Direct | May 9, 2018 (2d) |
| Feb 16, 2018 | UTMD | ↓ Sell | 1,000 | $90.70 | $91K | Direct | Feb 20, 2018 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other UTMD insiders
Open-market trades in the last 12 months
About Barbara A Payne's insider trades
Barbara A Payne is a director at Utah Medical Products (UTMD). Since Feb 16, 2018, Barbara has reported no open-market purchases and 20 sales worth $2.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include gifts (5 filings), option exercises (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UTMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.